S-Alpha Therapeutics (에스알파테라퓨틱스)
S-Alpha Therapeutics (에스알파테라퓨틱스)
Claim
Founded in 2019, S-Alpha Therapeutics develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology. Company has developed several digital therapeutic products in its R&D pipeline. Currently, company is conducting clinical trials to evaluate the efficacy, safety and feasibility of SAT-001 in several clinical sites in South Korea.Founded in 2019, S-Alpha Therapeutics develops digital therapeutics, a therapeutic intervention from Show More
Alpha Score
$ 18.49 M
Alpha Score
63.8
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0